LONDON, Oct. 15, 2026 (GLOBE NEWSWIRE) -- DaltonTx, the decision engine for drug discovery, today announces that it has been awarded a grant by the Gates Foundation to advance tuberculosis (TB) drug discovery programmes using its AI-enabled platform, Dalton. The award marks a…
Founded by leaders from OpenAI, Terremoto Biosciences, Meta, Devoted Health, and the White House, Warp is using AI and robotics to help biotech and pharma discover new medicines faster in the U.S. The company is backed by Lightspeed, IVP, Mayfield, Lux,…
AI drug discovery is often described with the image of AI coming up with new drug candidates, but its scope of application goes beyond just molecular design. However, 'companies have partnered,' 'a promising candidate has been found,' and 'efficacy has…
J.P. Morgan analyst Daniel Kerven maintained a Buy rating on RELX plc today and set a price target of £50.70. According to TipRanks, Kerven is ranked #1457 out of 12466 analysts. In addition to J.P. Morgan, RELX plc also received a Buy from…
Anthropic is expanding into biotechnology through drug-development partnerships, its own biology laboratory, and the acquisition of a company researching rare muscular diseases, bringing the artificial intelligence company deeper into the search for new medicines. In a new announcement, Anthropic outlined…
SAN FRANCISCO, October 27, 2026--Omabit raises $2M seed led by Bright Ventures to advance AI for scientific decision-making in drug development. Oops, something went wrong Omabit Announces Seed Financing to Advance Scientific Decision-Making in Drug Development Backed by Bright Ventures, Omabit connects…
/PRNewswire/ -- Genedata, the leading provider of enterprise software for biopharmaceutical R&D, today announced an expanded collaboration with Abcam, a global... The partnership combines Abcam's expertise in antibody development with Genedata's proprietary data model and enterprise platform to enhance data…
By The Robot Report Staff | October 28, 2026 Warp Sciences plans to create chemistry infrastructure for sovereign biotech. Source: deni AI, Adobe Stock Warp Sciences last week emerged from stealth with $215 million in funding to create infrastructure that enables biotech and pharmaceutical…
Aspen Neuroscience is pursuing a $150 million IPO to fund Parkinson’s disease stem cell therapies. Click here to read an analysis of ASPE stock now. - Aspen Neuroscience is pursuing a $150 million IPO to fund Parkinson’s disease stem cell therapies. - ASPE’s lead…
Co-authored IND submission preparation study results demonstrate ~97% reduction in time to first draft and 60% overall timeline compression SAN FRANCISCO, September 01, 2026--(BUSINESS WIRE)--Weave Bio, the leader in AI-native regulatory automation for drug development, today announced a collaboration with Takeda to…
Synthetic-biology and technology-platform biotechs - Ginkgo Bioworks, Twist Bioscience, Colossal, Recursion, Isomorphic Labs - and AI drug-discovery companies.
An article joins this feed when it matches these terms. Each one is also a search of its own.